An April securities filing disclosed that Dr. Patterson was a CytoDyn shareholder.
In the interview with the Journal, Dr. Patterson said he never received paperwork regarding his ownership in CytoDyn . "I've gotten little to no paperwork regarding that," he said. "I don't think of it as real."
On the question of Dr. Patterson's share ownership, Arian Colachis , CytoDyn's general counsel, pointed to the April filing.
"The document speaks for itself, and we have no further comment," she said.